Linden Invests in The Flexan Corporation
Leading global medical device parts manufacturer a strategic fit with Linden expertise.
CHICAGO, IL – February 5, 2015 – Linden Capital Partners (“Linden”), a Chicago-based healthcare private equity firm, announced today that it has completed an investment in The Flexan Corporation (“Flexan” or the “Company”), a leading global manufacturer of high-precision silicone and rubber parts predominately serving the medical device industry. The Company is headquartered in Chicago and operates manufacturing facilities in the greater Chicago area and China.
“Linden is a natural strategic fit for the Company due to their exclusive focus on healthcare and their deep medical products and contract manufacturing expertise,” said Scott Severson, Chief Executive Officer of Flexan. “Linden understands our industry and our culture, and can support both our organic growth and acquisition initiatives.”
“Flexan has distinguished itself through its people, track record, and proprietary capabilities,” said Linden Operating Partner Ron Labrum. Mr. Labrum, a 30-year medical products industry veteran, will join the Flexan Board of Directors as Chairman. Bruce Cohen and Frank Sullivan will join the board and will continue to serve as Presidents of the Flexan Corporation and FMI Inc., respectively. Mr. Severson will also join the Board.
“Partnering with Flexan is consistent with Linden’s decade-long strategy of collaborating with Operating Partners to invest in industry-leading companies within our targeted healthcare subsectors, and it marks a successful outcome of our dedicated contract manufacturing effort,” said Brian Miller, a Managing Partner at Linden. Flexan is the seventh and final platform investment from Linden’s second fund.
Kirkland & Ellis LLP served as legal advisors to Linden, and debt financing in support of the transaction was provided exclusively by Golub Capital. Mesirow Financial and Levenfeld Pearlstein LLC served as financial and legal advisors to Flexan.
About The Flexan Corporation
Founded in in 1946, Flexan is a leading global manufacturer of high-precision elastomer parts that are critical components in a broad array of products and industry applications. Flexan has over 500 employees and three manufacturing facilities, and operates two distinct but complementary business units (FMI and Flexan). FMI delivers clean-room manufactured silicone rubber molded components for use in Class II disposable and Class III implantable medical devices. Flexan is a custom molder whose expertise in molding difficult geometries and bonding rubber to metal has earned the company the reputation as an innovative provider across numerous attractive healthcare niches. For more information, please visit www.flexan.com and www.fmimed.com.
About Linden Capital Partners
Linden Capital Partners is a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries. Linden’s strategy is based upon three elements: i) healthcare and life science industry specialization, ii) integrated private equity and operating expertise, and iii) strategic relationships with large corporations. Linden invests in middle market platforms in the medical products, specialty distribution, pharmaceutical, and services segments of healthcare. For more information, please visit www.lindenllc.com.